AI Visionary: How April Stiles is Shaping Healthcare's Future

LANGHORNE, PA – March 09, 2026 – In a technology landscape often defined by disruption, April Stiles is championing a different approach: responsible transformation. The CEO of Perspecta, a leading provider of healthcare data management solutions, has been named a 2026 Female Trailblazer in SaaS by Software Equity Group (SEG), a prominent investment bank focused on the software sector. The prestigious, peer-nominated recognition highlights female executives who are not just driving growth but are fundamentally shaping the future of B2B software through innovation and impactful leadership.

Coming in alignment with International Women's Day, the award casts a spotlight on Stiles's pivotal role at the intersection of healthcare and artificial intelligence. Under her guidance, Perspecta is navigating the complexities of the U.S. healthcare system by focusing on a philosophy that prizes sustainable impact and trust above transient wins. While Stiles is being celebrated for her individual leadership, she is quick to share the credit.

"This recognition reflects not just individual achievement, but the collective innovation and commitment of the entire Perspecta team," said April Stiles, CEO of Perspecta.

A New Era of Leadership at Perspecta

April Stiles took the helm as CEO in January 2025, a planned succession after a successful tenure as the company's Chief Operating Officer and President of Group Health & Government. Bringing over 25 years of deep industry experience in healthcare and workers' compensation, her transition to the top leadership role marked a continuation of the company's strategic direction, but with a renewed and sharpened focus on platform expansion and AI-enabled capabilities.

Her impact was immediate and measurable. In 2025, Perspecta reported a record year for client growth, completing 670 new implementations and expanding its management to over 630 million provider records for 4,800 clients. This growth was built on the company's core promise: delivering the industry's highest provider data accuracy, which now exceeds a remarkable 95%. This level of precision is critical for the company's clients, which include four of the five largest health insurers in the nation.

Under Stiles's leadership, Perspecta has not only accelerated its revenue growth while maintaining profitability but has also significantly deepened its customer partnerships. Her philosophy centers on adaptability and accountability, fostering a culture that operates as a consultative partner rather than a mere vendor. This approach has solidified the company's position as a trusted force in a market where data integrity can directly impact patient care and operational efficiency.

The Precision Play: Navigating a Complex Market

Perspecta operates in one of the most dynamic and rapidly growing sectors of the economy: healthcare software as a service (SaaS). The global market, valued at over $32 billion in 2025, is projected to soar to more than $82 billion by 2031. This explosive growth is fueled by powerful tailwinds, including the shift to cloud-native systems, payer-driven automation, and strict government mandates for data interoperability.

Within this bustling market, Perspecta has carved out a critical niche in enterprise provider data management. The company's platform acts as a single, authoritative source of truth, consolidating fragmented and often contradictory data from countless sources. For its clients—health plans, workers' compensation organizations, and provider groups—this service is essential for everything from regulatory compliance and network optimization to enabling a better patient experience when searching for a doctor.

While the competitive landscape includes technology giants like Accenture, Deloitte, and IBM, Perspecta differentiates itself through its deep domain expertise and unwavering focus on data quality. Under Stiles, the company has doubled down on this strategy, expanding its presence across health plans and the workers' compensation market by proving its ability to deliver measurable performance outcomes. It's a precision play in a field where errors are costly, positioning the company not just as a technology provider but as a central pillar in the administrative infrastructure of American healthcare.

Architecting Trust in the Age of AI

Perhaps the most significant aspect of April Stiles's vision is her approach to artificial intelligence. As AI continues to permeate every corner of healthcare—from diagnostics to treatment planning—it brings both immense promise and significant peril. The industry is grappling with complex ethical questions around data privacy, algorithmic bias, and the need for transparency.

Regulatory bodies are stepping in to provide guardrails. The FDA now actively regulates AI-enabled medical devices (SaMD), while the Office of the National Coordinator for Health Information Technology (ONC) has issued its HTI-1 Final Rule. This rule mandates transparency for AI algorithms used in certified health IT, requiring developers to disclose key information about a model's performance, fairness, and safety—akin to a "nutrition label" for software.

It is within this high-stakes environment that Stiles's philosophy of responsible leadership truly stands out. She has been vocal about the need for disciplined execution and strong governance to accompany technological advancement.

"As AI transforms the software landscape, the opportunity for leaders is not simply to move fast, but to move responsibly," Stiles stated. "Technology alone doesn't create trust, disciplined execution, strong governance, and true partnership do."

This principle is at the heart of Perspecta's strategy. By focusing on aligning its AI capabilities with customer goals and embedding human oversight and responsible governance into its systems, the company is building solutions designed to deliver productivity gains without compromising the trust of clients or patients. This focus on building durable, trustworthy AI is a key differentiator and positions Perspecta to lead in the next generation of healthcare technology.

A Trailblazer Among Peers

The SEG Female Trailblazer award is significant not only for what it recognizes but also for how it is determined: through peer nomination. The honor reflects Stiles's standing within the industry as a respected leader known for her strategic foresight and ability to deliver sustained growth in a complex, ever-changing market.

Her achievement is part of a broader, encouraging trend of women ascending to top leadership roles in the health tech and SaaS industries. She joins a growing list of influential female executives, such as Kate Ryder of Maven Clinic and Kristen Valdes of b.Well, who are driving innovation and building transformative companies. These leaders are not only breaking barriers but are also bringing diverse perspectives that are critical to solving healthcare's most intractable problems.

Looking ahead, Stiles remains focused on expanding Perspecta's role in the ongoing transformation of healthcare. The company continues to explore new solutions aimed at enhancing the patient experience, simplifying access to care, and helping clients navigate an increasingly complicated regulatory environment. With a firm commitment to innovation, deep domain expertise, and a leadership philosophy grounded in trust and responsibility, April Stiles is positioning Perspecta to be an indispensable partner in building a more efficient and equitable healthcare system for years to come.